Elizabeth Rosenberg - Concepedia

Author

Elizabeth Rosenberg

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

Annpey Pong, E L Rosenberg, Elizabeth Rosenberg, Liang Chen

119

Publications

3.5K

Citations

H-Index

135

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)Virginia Commonwealth University MSD (Belgium)Merck (Japan)Virginia Commonwealth University Medical Center

About

Elizabeth Rosenberg is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	21	1.2K
2	Engineering	4	4	88
3	Natural Sciences	4	4	210
4	Health Sciences	2	2	78
5	Business	1	1	11

Elizabeth Rosenberg

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion Sarah E. Golding, Elizabeth Rosenberg, Nicholas C.K. Valerie, Molecular Cancer Therapeutics	2009	381
CXCR2 Antagonist MK-7123. A Phase 2 Proof-of-Concept Trial for Chronic Obstructive Pulmonary Disease Stephen I. Rennard, David C. Dale, James F. Donohue, American Journal of Respiratory and Critical Care Medicine	2015	251
ATM Kinase Inhibition Preferentially Sensitizes p53-Mutant Glioma to Ionizing Radiation Laura Biddlestone-Thorpe, Sajjad Muhammad, Elizabeth Rosenberg, Clinical Cancer Research	2013	219
Extracellular Signal-Related Kinase Positively Regulates Ataxia Telangiectasia Mutated, Homologous Recombination Repair, and the DNA Damage Response Sarah E. Golding, Elizabeth Rosenberg, Steven J. Neill, Cancer Research	2007	189
Odanacatib in the treatment of postmenopausal women with low bone mineral density: Five years of continued therapy in a phase 2 study Bente Langdahl, Neil Binkley, Henry G. Bone, Journal of Bone and Mineral Research OsteopathyGynecologyContinued TherapyPharmacotherapyContinuous Odn	2012	160
Double Strand Break Repair by Homologous Recombination Is Regulated by Cell Cycle-independent Signaling via ATM in Human Glioma Cells Sarah E. Golding, Elizabeth Rosenberg, Ashraf Khalil, Journal of Biological Chemistry Molecular BiologyCell CycleGliomaTumor BiologyNeuro-oncology	2004	123
Bone Density, Turnover, and Estimated Strength in Postmenopausal Women Treated With Odanacatib: A Randomized Trial Kim Brixen, Roland Chapurlat, Angela M. Cheung, The Journal of Clinical Endocrinology & Metabolism	2013	122
Once-weekly dose of 8400 IU vitamin D3 compared with placebo: effects on neuromuscular function and tolerability in older adults with vitamin D insufficiency Paul Lips, Neil Binkley, Michael Pfeifer, American Journal of Clinical Nutrition Vitamin D InsufficiencyGeriatricsClinical NutritionRehabilitationNeurology	2010	116
A cross-sectional study of bone turnover markers in healthy premenopausal women Anne E. de Papp, Henry G. Bone, Michael P. Caulfield, Bone Bone Turnover MarkersBone HealthReproductive HealthGynecologyMaternal Health	2007	101
Dynamic inhibition of ATM kinase provides a strategy for glioblastoma multiforme radiosensitization and growth control Sarah E. Golding, Elizabeth Rosenberg, Bret R. Adams, Cell Cycle Growth ControlHigh-grade GliomasCancer BiologyGliomaTumor Biology	2012	97

Page 1